Interleukin 2 induces a transient downregulation of protein phosphatase 1 and 2A activity in human T cells

被引:14
作者
Brockdorff, J
Nielsen, M
Dobson, P
Geisler, C
Ropke, C
Svejgaard, A
Odum, N
机构
[1] UNIV COPENHAGEN, INST MED ANAT, DK-2200 COPENHAGEN, DENMARK
[2] NATL UNIV HOSP, TISSUE TYPING LAB, COPENHAGEN, DENMARK
[3] UNIV SHEFFIELD, SCH MED, INST CANC STUDIES, SHEFFIELD, S YORKSHIRE, ENGLAND
来源
TISSUE ANTIGENS | 1997年 / 49卷 / 03期
关键词
interleukin-2; IL-2; protein phosphatase; PP1; PP2A; signal transduction; T cell;
D O I
10.1111/j.1399-0039.1997.tb02743.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Stimulation of human CD4(+) T cell lines with interleukin 2 (IL-2) induces tyrosine, serine and threonine phosphorylation of a series of proteins involved in the IL-2 receptor (IL-2R) signaling pathway. Here, we examined whether IL-2 induces changes in the activity of protein serine/threonine phosphatases in antigen specific, CD4(+) human T cell lines. Using inhibitors of protein phosphatases 1 (PPI), PP2A, and PP2B, we provide evidence, that IL-2 induces a downregulation of PP activity in the cytoplasmic/membrane fraction. Thus, IL-2R ligation for 30 min triggers a 16 percent decrease in total PP2A activity (p<0.00005, n=17) and a seven percent decrease in PP1 activity (p<0.00005, n=17). Cytokine-induced downregulation of PP2A activity reaches a maximum 60 min after IL-2R ligation, and returns to baseline levels within two hours. Downregulation of PP1 activity reaches a maximum after 30 min and is largely reversed one hour after IL-2 stimulation. As determined from immunoblotting experiments using a specific anti-PP1 or anti-PP2A antibody, the amount of PP1 and PP2A recovered from cytosolic/membrane fraction remains unchanged after IL-2 treatment suggesting that the drop in PP1/PP2A activity might be due to a regulatory change rather than to a change in the amount of PP1 and PP2A. In conclusion, we provide evidence, for the first time, that IL-2 induces a transient downregulation of PP2A activity in T cells. In addition, our findings indicate that cytoplasmic PP1 activity is transiently downregulated following IL-2R ligation in antigen-specific, human CD4(+) T cells.
引用
收藏
页码:228 / 235
页数:8
相关论文
共 31 条
[1]   INACTIVATION OF P42 MAP KINASE BY PROTEIN PHOSPHATASE 2A AND A PROTEIN-TYROSINE-PHOSPHATASE, BUT NOT CL100, IN VARIOUS CELL-LINES [J].
ALESSI, DR ;
GOMEZ, N ;
MOORHEAD, C ;
LEWIS, T ;
KEYSE, SM ;
COHEN, P .
CURRENT BIOLOGY, 1995, 5 (03) :283-295
[2]   INHIBITORY EFFECT OF A MARINE-SPONGE TOXIN, OKADAIC ACID, ON PROTEIN PHOSPHATASES - SPECIFICITY AND KINETICS [J].
BIALOJAN, C ;
TAKAI, A .
BIOCHEMICAL JOURNAL, 1988, 256 (01) :283-290
[3]  
CHEN J, 1994, J BIOL CHEM, V269, P7957
[4]   REGULATION OF PROTEIN SERINE-THREONINE PHOSPHATASE TYPE-2A BY TYROSINE PHOSPHORYLATION [J].
CHEN, J ;
MARTIN, BL ;
BRAUTIGAN, DL .
SCIENCE, 1992, 257 (5074) :1261-1264
[5]   THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES [J].
COHEN, P .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :453-508
[6]   LATENT FORMS OF TYPE-1 PROTEIN PHOSPHATASE IN RABBIT SKELETAL-MUSCLE [J].
GRUPPUSO, PA ;
SHRINER, CL ;
BRAUTIGAN, DL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (03) :1174-1181
[7]   ACTIVATION OF PROTEIN-KINASES AND THE INACTIVATION OF PROTEIN PHOSPHATASE 2A IN TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 SIGNAL-TRANSDUCTION PATHWAYS [J].
GUY, GR ;
PHILP, R ;
TAN, YH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 229 (02) :503-511
[8]   INTERACTION OF THE IL-2 RECEPTOR WITH THE SRC-FAMILY KINASE-P56LCK - IDENTIFICATION OF NOVEL INTERMOLECULAR ASSOCIATION [J].
HATAKEYAMA, M ;
KONO, T ;
KOBAYASHI, N ;
KAWAHARA, A ;
LEVIN, SD ;
PERLMUTTER, RM ;
TANIGUCHI, T .
SCIENCE, 1991, 252 (5012) :1523-1528
[9]   CHARACTERIZATION OF NATURAL TOXINS WITH INHIBITORY ACTIVITY AGAINST SERINE THREONINE PROTEIN PHOSPHATASES [J].
HONKANAN, RE ;
CODISPOTI, BA ;
TSE, K ;
BOYNTON, AL .
TOXICON, 1994, 32 (03) :339-350
[10]   IDENTIFICATION AND PURIFICATION OF HUMAN STAT PROTEINS ACTIVATED IN RESPONSE TO INTERLEUKIN-2 [J].
HOU, JZ ;
SCHINDLER, U ;
HENZEL, WJ ;
WONG, SC ;
MCKNIGHT, SL .
IMMUNITY, 1995, 2 (04) :321-329